'Design to Value: The architecture of holistic design and creative technology' - Excerpt 1

These projects can be seen as bespoke and are more expensive.. Bryden Wood’ response to Passivhaus’ challenges.

This means the product is used more times over its life, making it more worthwhile to manufacture and reducing the number needed, which equates to a more sustainable construction practice.. Take-back schemes, where manufacturers and suppliers will take back products and materials at the end of their life, enable waste to be minimised and known materials to be recycled within the production process.This reduces raw material requirements for new products.. Minimise impact and waste for sustainable construction.

Use low impact materials by considering the environmental impact at specification stage, alongside cost and technical considerations.This also includes the manufacturing location of materials and the transportation distance to site..The recycled content of materials should be maximised without significantly impacting the technical characteristics of the material..

Designing out waste can be achieved with clever and simple use of materials, eg.altering the centre point of ceiling tiles to limit offcuts to a single side of the room, rather than both sides..

Designing with/for components promotes offsite assembly of repeated modules.

Any leftovers from building the components can be used on subsequent projects, recycled onsite or restocked, minimising wastage.. How can we minimise risk in the building sector?.The more consistent and proactive enablers, the better; they could create an environment where positive change can happen quickly within a clear, consistent economic playing field.. New technologies, including AI models to help predict the presence of harmful impurities alongside developments in impurity detection at parts per trillion levels, could be extremely useful.

In conjunction with testing/development facilities, these technologies could accelerate problem finding and solving..Fear, and the inertia of uncertainty, is lessened by shining a light on the technological and economic opportunities.

This includes sharing insights from the R&D-led industry with contract manufacturers, generics and start-ups..Start-up companies need investment to scale up quickly to support the pharmaceutical industry.